What is Scorpius Holdings's earnings per share (EPS)?

Scorpius Holdings (SCPX) reported diluted earnings per share of $-13.04 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Scorpius Holdings Financials

SCPX

Source SEC Filings (10-K/10-Q) Data as of Sep 30, 2025 Currency USD FYE December

This page shows Scorpius Holdings (SCPX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SCPX FY2024 2026-04-22

Scorpius’s business model currently depends on external capital because operating cash burn still overwhelms its revenue base.

In FY2024, financing inflows of $25.6M almost offset operating cash burn of -$26.0M. With only $1.0M of cash and a current ratio of 0.1x, the business was effectively being funded period by period rather than by internally generated cash.

Between FY2023 and FY2024, the net loss improved to -$32.8M from -$45.2M, and operating cash flow improved in the same direction. That makes earnings quality relatively easy to read: the reported loss is also a real cash drain, not mainly a noncash accounting effect.

The company spent just $875K on capex in FY2024 while spending $14.3M on R&D, so its cash needs come mainly from ongoing development work rather than building a heavy physical asset base. Meanwhile, liabilities now sit close to assets, so the balance sheet offers little cushion against another year of similar burn.

Financial Health Signals

Financial health score pending refresh

We are recalculating Scorpius Holdings's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Altman Z-Score Distress

-13.55

Scorpius Holdings scores -13.55, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.5M) relative to total liabilities ($37.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/8

Scorpius Holdings passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.79x

For every $1 of reported earnings, Scorpius Holdings generates $0.79 in operating cash flow (-$26.0M OCF vs -$32.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.2M

YoY-10.7%

5Y CAGR+15.4%

10Y CAGR+65.5%

Scorpius Holdings generated $6.2M in revenue in fiscal year 2024. This represents a decrease of 10.7% from the prior year.

EBITDA

-$26.4M

YoY+25.6%

Scorpius Holdings's EBITDA was -$26.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 25.6% from the prior year.

Net Income

-$32.8M

YoY+27.4%

Scorpius Holdings reported -$32.8M in net income in fiscal year 2024. This represents an increase of 27.4% from the prior year.

EPS (Diluted)

$-13.04

Scorpius Holdings earned $-13.04 per diluted share (EPS) in fiscal year 2024.

Cash & Balance Sheet

Free Cash Flow

-$26.9M

YoY+19.8%

Scorpius Holdings generated -$26.9M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 19.8% from the prior year.

Cash & Debt

$1.0M

YoY+455.9%

5Y CAGR-35.3%

10Y CAGR-12.1%

Scorpius Holdings held $1.0M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

Scorpius Holdings had 5M shares outstanding in fiscal year 2024.

Margins & Returns

Gross Margin

48.8%

YoY-12.1pp

Scorpius Holdings's gross margin was 48.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 12.1 percentage points from the prior year.

Operating Margin

-538.2%

YoY+62.7pp

5Y CAGR+142.2pp

10Y CAGR+29501.2pp

Scorpius Holdings's operating margin was -538.2% in fiscal year 2024, reflecting core business profitability. This is up 62.7 percentage points from the prior year.

Net Margin

-525.5%

YoY+120.9pp

5Y CAGR+131.0pp

10Y CAGR+28532.9pp

Scorpius Holdings's net profit margin was -525.5% in fiscal year 2024, showing the share of revenue converted to profit. This is up 120.9 percentage points from the prior year.

Return on Equity

-520.8%

YoY-376.8pp

5Y CAGR-373.3pp

10Y CAGR-420.6pp

Scorpius Holdings's ROE was -520.8% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 376.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$14.3M

YoY-28.8%

5Y CAGR+1.9%

10Y CAGR+17.5%

Scorpius Holdings invested $14.3M in research and development in fiscal year 2024. This represents a decrease of 28.8% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$875K

YoY-55.9%

5Y CAGR+27.0%

10Y CAGR+6.7%

Scorpius Holdings invested $875K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 55.9% from the prior year.

SCPX Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$6.2M-10.7%	$7.0M+1789.6%	$370K-82.5%	$2.1M-28.3%	$2.9M-3.3%	$3.0M
Cost of Revenue	$3.2M+16.8%	$2.7M+3266.7%	$81K	N/A	N/A	N/A
Gross Profit	$3.0M-28.4%	$4.3M+1373.9%	$289K	N/A	N/A	N/A
R&D Expenses	$14.3M-28.8%	$20.1M-0.5%	$20.2M+22.9%	$16.5M+27.2%	$12.9M-0.6%	$13.0M
SG&A Expenses	$21.6M-17.6%	$26.2M+30.0%	$20.1M+19.6%	$16.8M+12.7%	$14.9M+58.4%	$9.4M
Operating Income	-$33.6M+20.1%	-$42.0M-4.5%	-$40.2M-13.6%	-$35.4M-35.6%	-$26.1M-25.9%	-$20.7M
Interest Expense	N/A	N/A	$987K	N/A	N/A	N/A
Income Tax	N/A	-$571K-164.5%	-$216K-47.9%	-$146K	N/A	$45K
Net Income	-$32.8M+27.4%	-$45.2M-4.1%	-$43.4M-23.8%	-$35.1M-34.6%	-$26.0M-30.1%	-$20.0M
EPS (Diluted)	$-13.04	$-347.50-20341.2%	$-1.70-20.6%	$-1.41+13.5%	$-1.63	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$230K+1.0%	$228K+7.2%	$212K-79.7%	$1.0M+13.5%	$922K+21.4%	$760K-78.4%	$3.5M-27.5%	$4.8M
Cost of Revenue	$145K-32.0%	$214K-43.2%	$376K-33.8%	$568K-33.3%	$852K+1.7%	$838K-10.7%	$938K-21.6%	$1.2M
Gross Profit	$84K+508.8%	$14K+108.5%	-$164K-134.2%	$479K+580.4%	$70K+190.2%	-$78K-103.0%	$2.6M-29.5%	$3.7M
R&D Expenses	$2.5M-11.7%	$2.8M-11.8%	$3.2M+24.9%	$2.5M-41.0%	$4.3M+19.1%	$3.6M-7.2%	$3.9M+10.5%	$3.5M
SG&A Expenses	$2.3M-21.7%	$3.0M-25.2%	$4.0M-32.4%	$5.9M+5.2%	$5.6M+12.3%	$5.0M+0.1%	$5.0M-23.7%	$6.6M
Operating Income	-$4.7M+18.1%	-$5.8M+58.1%	-$13.8M-47.5%	-$9.4M+3.3%	-$9.7M-4.3%	-$9.3M-74.1%	-$5.3M+17.3%	-$6.4M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	$0	$0	N/A	N/A
Net Income	-$984K+75.9%	-$4.1M+61.9%	-$10.7M-14.0%	-$9.4M+7.0%	-$10.1M-14.0%	-$8.9M-100.9%	-$4.4M+18.3%	-$5.4M
EPS (Diluted)	$-0.02+77.8%	$-0.09	$-1.16	N/A	$-1.43	$-26.98+14.0%	$-31.38	N/A

SCPX Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$39.2M-23.2%	$51.0M-51.1%	$104.4M-13.7%	$121.0M-2.6%	$124.2M+378.5%	$26.0M
Current Assets	$3.3M-31.5%	$4.8M-90.5%	$50.1M-49.6%	$99.3M-12.7%	$113.8M+648.2%	$15.2M
Cash & Equivalents	$1.0M+455.9%	$185K-94.2%	$3.2M-60.4%	$8.1M-26.3%	$10.9M+20.9%	$9.0M
Inventory	$199K-78.1%	$909K	N/A	N/A	N/A	N/A
Accounts Receivable	$143K-61.8%	$375K+360.6%	$81K+23.3%	$66K-62.7%	$177K+406.6%	$35K
Goodwill	N/A	N/A	$3.3M	N/A	$1.5M0.0%	$1.5M
Total Liabilities	$37.5M+64.9%	$22.7M-28.8%	$32.0M+258.0%	$8.9M+2.6%	$8.7M-32.0%	$12.8M
Current Liabilities	$24.3M+140.5%	$10.1M-44.0%	$18.0M+282.1%	$4.7M+29.1%	$3.7M-56.6%	$8.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$6.3M-79.9%	$31.4M-57.5%	$73.9M-34.6%	$113.1M-2.7%	$116.2M+756.5%	$13.6M
Retained Earnings	-$287.2M-12.9%	-$254.4M-21.6%	-$209.2M-26.2%	-$165.7M-26.8%	-$130.6M-24.9%	-$104.6M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$20.8M-3.7%	$21.6M-8.5%	$23.6M-39.8%	$39.2M-15.8%	$46.5M-0.3%	$46.7M-7.6%	$50.5M-1.0%	$51.0M
Current Assets	$2.1M+40.8%	$1.5M-26.1%	$2.0M-37.4%	$3.3M-48.9%	$6.4M+84.8%	$3.5M-28.5%	$4.8M+1.5%	$4.8M
Cash & Equivalents	$582K+11.7%	$521K+175.5%	$189K-81.6%	$1.0M-77.5%	$4.6M+209.7%	$1.5M-5.3%	$1.6M+740.8%	$185K
Inventory	$203K-0.1%	$204K0.0%	$204K+2.5%	$199K+13.5%	$175K+147.2%	$71K-95.1%	$1.4M+59.1%	$909K
Accounts Receivable	$180K+617.9%	$25K-88.1%	$210K+46.2%	$143K-29.4%	$203K-84.6%	$1.3M+146.6%	$535K+42.6%	$375K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$22.1M-8.1%	$24.1M-20.2%	$30.1M-19.6%	$37.5M+70.5%	$22.0M-11.4%	$24.8M-1.7%	$25.2M+11.0%	$22.7M
Current Liabilities	$22.2M-4.6%	$23.3M+0.6%	$23.1M-4.7%	$24.3M+135.0%	$10.3M-4.5%	$10.8M-15.6%	$12.8M+27.0%	$10.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$1.3M+46.5%	-$2.5M-81.8%	-$1.4M-121.7%	$6.3M-78.1%	$28.7M+12.2%	$25.6M-10.4%	$28.6M-8.9%	$31.4M
Retained Earnings	-$303.0M-0.3%	-$302.0M-1.4%	-$297.9M-3.7%	-$287.2M-3.4%	-$277.8M-3.8%	-$267.7M-3.4%	-$258.8M-1.7%	-$254.4M

SCPX Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$26.0M+17.5%	-$31.5M-453.2%	-$5.7M+85.0%	-$38.1M-73.1%	-$22.0M-71.5%	-$12.8M
Capital Expenditures	$875K-55.9%	$2.0M-90.1%	$20.1M+956.2%	$1.9M+463.6%	$338K+27.4%	$265K
Free Cash Flow	-$26.9M+19.8%	-$33.5M-29.8%	-$25.8M+35.5%	-$40.0M-79.0%	-$22.4M-70.6%	-$13.1M
Investing Cash Flow	$1.2M-96.2%	$32.2M+193.3%	$11.0M+12.5%	$9.8M+110.2%	-$95.4M-32356.0%	-$294K
Financing Cash Flow	$25.6M+386.4%	-$9.0M-82.4%	-$4.9M-119.3%	$25.5M-78.6%	$119.3M+626233.5%	$19K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$2.9M+14.3%	-$3.4M-1.0%	-$3.4M+36.3%	-$5.3M+47.4%	-$10.1M-68.4%	-$6.0M-27.5%	-$4.7M-334.6%	-$1.1M
Capital Expenditures	$0	$0-100.0%	$58K-67.8%	$179K	$0-100.0%	$396K+32.4%	$299K+125.3%	$133K
Free Cash Flow	-$2.9M+14.3%	-$3.4M+0.7%	-$3.4M+37.3%	-$5.5M+45.6%	-$10.1M-57.9%	-$6.4M-27.8%	-$5.0M-311.6%	-$1.2M
Investing Cash Flow	-$19K-131.8%	$60K+250.5%	$17K+101.1%	-$1.6M-562.2%	$349K+214.9%	-$304K-110.9%	$2.8M+32.5%	$2.1M
Financing Cash Flow	$3.0M-18.5%	$3.7M+46.2%	$2.5M-25.3%	$3.4M-73.7%	$12.8M+106.6%	$6.2M+89.2%	$3.3M+152.8%	-$6.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SCPX Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	48.8%-12.1pp	60.9%-17.2pp	78.0%	N/A	N/A	N/A
Operating Margin	-538.2%+62.7pp	-600.9%+10264.9pp	-10865.8%-9189.4pp	-1676.4%-790.2pp	-886.2%-205.8pp	-680.4%
Net Margin	-525.5%+120.9pp	-646.4%+11087.1pp	-11733.5%-10073.6pp	-1659.9%-776.3pp	-883.6%-227.1pp	-656.5%
Return on Equity	-520.8%-376.8pp	-144.0%-85.3pp	-58.8%-27.8pp	-31.0%-8.6pp	-22.4%+125.1pp	-147.5%
Return on Assets	-83.7%+4.9pp	-88.6%-47.0pp	-41.6%-12.6pp	-29.0%-8.0pp	-21.0%+56.1pp	-77.1%
Current Ratio	0.13-0.3	0.47-2.3	2.77-18.3	21.04-10.1	31.12+29.3	1.80
Debt-to-Equity	5.95+5.2	0.72+0.3	0.43+0.4	0.080.0	0.07-0.9	0.94
FCF Margin	-430.6%+48.6pp	-479.2%+6495.4pp	-6974.6%-5079.8pp	-1894.8%-1136.3pp	-758.5%-328.7pp	-429.7%

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	36.8%+30.6pp	6.1%+83.3pp	-77.2%-122.9pp	45.7%+38.1pp	7.6%+17.9pp	-10.3%-83.6pp	73.3%-2.0pp	75.3%
Operating Margin	-2056.8%+481.4pp	-2538.2%+3957.8pp	-6496.0%-5602.7pp	-893.3%+154.5pp	-1047.8%+171.1pp	-1218.9%-1067.5pp	-151.4%-18.7pp	-132.7%
Net Margin	-428.3%+1365.0pp	-1793.3%+3254.5pp	-5047.8%-4149.6pp	-898.1%+198.4pp	-1096.5%+71.3pp	-1167.8%-1042.1pp	-125.7%-14.2pp	-111.5%
Return on Equity	N/A	N/A	N/A	-149.2%-114.0pp	-35.2%-0.6pp	-34.6%-19.2pp	-15.4%+1.8pp	-17.2%
Return on Assets	-4.7%+14.2pp	-18.9%+26.5pp	-45.4%-21.4pp	-24.0%-2.3pp	-21.7%-2.7pp	-19.0%-10.3pp	-8.8%+1.9pp	-10.6%
Current Ratio	0.10+0.0	0.06-0.0	0.09-0.0	0.13-0.5	0.62+0.3	0.32-0.1	0.38-0.1	0.47
Debt-to-Equity	N/A	N/A	N/A	5.95+5.2	0.77-0.2	0.97+0.1	0.88+0.2	0.72
FCF Margin	-1269.3%+227.4pp	-1496.7%+118.9pp	-1615.6%-1093.2pp	-522.4%+568.2pp	-1090.6%-252.4pp	-838.3%-696.5pp	-141.8%-116.8pp	-25.0%

Note: The current ratio is below 1.0 (0.13), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Vincerx Pharma Inc VINC

$3.5M

Panbela Therapeutics Inc PBLA

$243K

Trevena Inc TRVN

$1.3M

Endonovo Therape ENDV

$145K

Globestar Therapeutics Corp GSTC

$124K

Frequently Asked Questions

What is Scorpius Holdings's annual revenue?

Scorpius Holdings (SCPX) reported $6.2M in total revenue for fiscal year 2024. This represents a -10.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Scorpius Holdings's revenue growing?

Scorpius Holdings (SCPX) revenue declined by 10.7% year-over-year, from $7.0M to $6.2M in fiscal year 2024.

Is Scorpius Holdings profitable?

No, Scorpius Holdings (SCPX) reported a net income of -$32.8M in fiscal year 2024, with a net profit margin of -525.5%.

What is Scorpius Holdings's EBITDA?

Scorpius Holdings (SCPX) had EBITDA of -$26.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Scorpius Holdings's gross margin?

Scorpius Holdings (SCPX) had a gross margin of 48.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Scorpius Holdings's operating margin?

Scorpius Holdings (SCPX) had an operating margin of -538.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Scorpius Holdings's net profit margin?

Scorpius Holdings (SCPX) had a net profit margin of -525.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Scorpius Holdings's return on equity (ROE)?

Scorpius Holdings (SCPX) has a return on equity of -520.8% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Scorpius Holdings's free cash flow?

Scorpius Holdings (SCPX) generated -$26.9M in free cash flow during fiscal year 2024. This represents a 19.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Scorpius Holdings's operating cash flow?

Scorpius Holdings (SCPX) generated -$26.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Scorpius Holdings's total assets?

Scorpius Holdings (SCPX) had $39.2M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Scorpius Holdings's capital expenditures?

Scorpius Holdings (SCPX) invested $875K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does Scorpius Holdings spend on research and development?

Scorpius Holdings (SCPX) invested $14.3M in research and development during fiscal year 2024.

How many shares does Scorpius Holdings have outstanding?

Scorpius Holdings (SCPX) had 5M shares outstanding as of fiscal year 2024.

What is Scorpius Holdings's current ratio?

Scorpius Holdings (SCPX) had a current ratio of 0.13 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is Scorpius Holdings's debt-to-equity ratio?

Scorpius Holdings (SCPX) had a debt-to-equity ratio of 5.95 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Scorpius Holdings's return on assets (ROA)?

Scorpius Holdings (SCPX) had a return on assets of -83.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Scorpius Holdings's cash runway?

Based on fiscal year 2024 data, Scorpius Holdings (SCPX) had $1.0M in cash against an annual operating cash burn of $26.0M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Scorpius Holdings's Altman Z-Score?

Scorpius Holdings (SCPX) has an Altman Z-Score of -13.55, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Scorpius Holdings's Piotroski F-Score?

Scorpius Holdings (SCPX) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Scorpius Holdings's earnings high quality?

Scorpius Holdings (SCPX) has an earnings quality ratio of 0.79x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.